| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 08/15/2002 | WO2002062829A1 Peptide derivatives |
| 08/15/2002 | WO2002062828A2 Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/15/2002 | WO2002062810A2 Linkable sialyl lewis x analogs |
| 08/15/2002 | WO2002062373A2 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/15/2002 | WO2002062372A2 Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/15/2002 | WO2002050101A8 Retinoblastoma-binding protein |
| 08/15/2002 | WO2002030955A3 Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | WO2002000263A3 Tripeptide prodrug compounds |
| 08/15/2002 | WO2001085977A3 Chemoenzymatic synthesis of neotame |
| 08/15/2002 | WO2000008048A3 Inhibitor of histone deacetylase |
| 08/15/2002 | US20020111512 Dynamic resolution of isomers and resolved isomers |
| 08/15/2002 | US20020111461 Peptidomimetic compound for us ein the treatment of diabetes |
| 08/15/2002 | US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/15/2002 | US20020111341 Bicyclic amino-pyrazinone compounds |
| 08/15/2002 | US20020111338 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 08/15/2002 | US20020111313 Tripeptide dosage |
| 08/14/2002 | EP1231215A1 Process for the production of aspartyldipeptide ester derivatives, novel intermediates therefor and process for the production of the intermediates |
| 08/14/2002 | EP1230260A1 Hcv ns3 protease inhibitors |
| 08/14/2002 | EP1230259A1 S-allylmercaptoglutathione and uses thereof |
| 08/14/2002 | EP0922054B1 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 08/14/2002 | EP0868526B1 PROCESS FOR PREPARING N-ACETYL(L)-4-CYANOPHENYLALANINE Ac-(L)-Phe(4-CN)-OH AND N-ACETYL-(L)-p-AMIDINOPHENYLALANINE-CYCLOHEXYLGLYCINE-BETA-(3-N-METHYLPYRIDINIUM)-ALANINE Ac-(L)-pAph-Chg-PalMe(3)-NH2 |
| 08/14/2002 | EP0722439B1 Hiv protease inhibitors |
| 08/14/2002 | DE10105041A1 Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten Tripeptides and tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/14/2002 | DE10105040A1 Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/14/2002 | DE10105038A1 Tripeptide und Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/14/2002 | CN1364163A Method for producing 2-aminomethyl-4-cyano-thiazol |
| 08/13/2002 | US6433177 Reacting n-carboxyanhydride and butylamine |
| 08/13/2002 | US6433171 Dipeptide derivatives |
| 08/13/2002 | US6433164 Substituted on ring carbon #9 by a primary amine which may or may not be protected; dehydrogenation of the octohydro derivative; drugs |
| 08/13/2002 | US6432955 Heterocyclic derivatives and their use as antithrombotic agents |
| 08/13/2002 | US6432945 Dipeptide derivatives |
| 08/13/2002 | US6432944 Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives |
| 08/13/2002 | US6432933 Malaria therapy; alzheimer's disorders |
| 08/13/2002 | US6432922 Antitumor agents; angiogenesis inhibitors |
| 08/13/2002 | US6432921 Oligopeptides |
| 08/13/2002 | US6432920 Peptide library |
| 08/13/2002 | CA2108170C Method of separating a peptide from a resin |
| 08/13/2002 | CA2045594C Immunogenic compositions against gastrin peptides |
| 08/08/2002 | WO2002060926A2 Hepatitis c tripeptide inhibitors |
| 08/08/2002 | WO2002060432A1 Hypoglycemic agent |
| 08/08/2002 | WO2001093840A3 Ligands of integrin receptors |
| 08/08/2002 | US20020107204 Protease-activated receptor-1 or 2 (PAR-1, PAR-2) |
| 08/08/2002 | US20020107202 Complementary peptides for the proline-glycine-proline sequence as antagonists of polymorphonuclear leukocyte chemoattractants; treating alkali-injuried eyes |
| 08/08/2002 | US20020107181 Novel hepatitis C virus ("HCV") protease inhibitors and pharmaceutical compositions comprising them optionally with viricide ribavirin and interferon |
| 08/08/2002 | US20020106640 Peptide for use in the treatment and prevention of viral infection |
| 08/08/2002 | DE10105039A1 Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten Tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/08/2002 | CA2436425A1 Hypoglycemic agent |
| 08/08/2002 | CA2429359A1 Hepatitis c tripeptide inhibitors |
| 08/07/2002 | EP1229122A2 Chimeric isoprenoid synthases and uses thereof |
| 08/07/2002 | EP1228076A1 A substantially cell membrane impermeable compound and use thereof |
| 08/07/2002 | EP1228061A1 Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors |
| 08/07/2002 | EP1227848A2 Method for linking molecular substances |
| 08/07/2002 | EP1227847A2 Inhibitors of the endothelin signalling pathway and alphavbeta3 integrin receptor antagonists for combination therapy |
| 08/07/2002 | EP1227813A1 Reverse-turn mimetics and methods relating thereto |
| 08/07/2002 | EP0835265B1 Platelet aggregation inhibitors containing c-terminal aminergic side chain amino acid residues |
| 08/07/2002 | CN1362967A Modulators for beta-amyloid peptide aggregation comprising D-amino acids |
| 08/07/2002 | CN1088706C Novel heterocyclic amide compounds and medicinal uses thereof |
| 08/06/2002 | US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis |
| 08/06/2002 | US6429288 Peptides containing an arginine mimetic for the treatment of bone metabolic disorders, their production, and drugs containing these compounds |
| 08/06/2002 | US6428983 Histone deacetylase as target for antiprotozoal agents |
| 08/06/2002 | CA1341380C Process for the preparation of n-alkylated amino acids and their esters, use in the synthesis of carboxyalkyl dipeptides |
| 08/01/2002 | WO2002059293A2 Process and compositions for peptide, protein and peptidomimetic synthesis |
| 08/01/2002 | WO2002059141A1 Peptide derivatives |
| 08/01/2002 | WO2002059131A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059130A1 Formulation of boronic acid compounds |
| 08/01/2002 | WO2002059095A1 Melanocortin receptor agonists |
| 08/01/2002 | WO2002059065A2 Oligo or polyalkylene glycol-coupled thrombin inhibitors |
| 08/01/2002 | WO2002058589A2 Agents and methods for promoting bone growth |
| 08/01/2002 | WO2002042278A3 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 08/01/2002 | WO2002009649A8 Cell internalized peptide-drug conjugates |
| 08/01/2002 | WO2002000684A3 Method of obtaining peptides with tissue-specific activity and pharmaceutical compositions on their basis |
| 08/01/2002 | WO2001098367A3 Neuroactive peptides for treatment of hypoxia and related conditions |
| 08/01/2002 | WO2001081325A3 Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties |
| 08/01/2002 | WO2001068655A3 Caprolactam derivatives and uses thereof |
| 08/01/2002 | WO2001002332A9 Process for the preparation of 3,3-dimethylbutanal |
| 08/01/2002 | US20020103341 Annexin derivatives with endogenous chelation sites |
| 08/01/2002 | US20020103336 Cloning of chicken anemia dna |
| 08/01/2002 | US20020103184 Cyclic malonamides as inhibitors of a beta protein production |
| 08/01/2002 | US20020103138 Modulating the immune system for more efficient immune response to malignant cells |
| 08/01/2002 | US20020103136 Conjugates useful in the treatment of prostate cancer |
| 08/01/2002 | US20020103133 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 08/01/2002 | US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease |
| 08/01/2002 | US20020102723 Nucleotide sequences coding polypeptide for use in diagnosis and treatment of pancreatic defects |
| 08/01/2002 | US20020102235 Novel imidazolidinones as NS3-serine protease inhibitors of hepatitis C virus |
| 08/01/2002 | DE10102878A1 Oligo- oder Polyalkylengekoppelte Thrombininhibitoren Oligo- or Polyalkylengekoppelte thrombin inhibitors |
| 08/01/2002 | CA2435124A1 Formulation of boronic acid compounds |
| 08/01/2002 | CA2432988A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2426154A1 Agents and methods for promoting bone growth |
| 07/31/2002 | EP1227104A1 Processes for producing and purifying aspartame derivatives and process for producing production intermediates |
| 07/31/2002 | EP1226267A1 Process for producing a product containing antihypertensive tripeptides |
| 07/31/2002 | EP1226237A2 Method of identifying inhibitors of cdc25 |
| 07/31/2002 | EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| 07/31/2002 | EP1226160A2 Novel antiarrhythmic peptides |
| 07/31/2002 | EP1226159A1 Substituted dipeptides having nos inhibiting activity |
| 07/31/2002 | EP1226158A1 Process for preparing peptide intermediates |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP0833837B1 Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide |
| 07/31/2002 | EP0764152B1 Substituted indolylmethylene-oxindole analogues as tyrosine kinase inhibitors |
| 07/31/2002 | CN1088456C Substituted oxazolidine calpain and/or cathepsin B inhibitors |